Muscle invasive bladder cancer and radical cystectomy: a risk predictive model

被引:1
|
作者
Tfaily, Mohamad Ali [1 ,2 ]
Tamim, Hani [2 ]
El Hajj, Albert [3 ]
Mukherji, Deborah [2 ,4 ]
机构
[1] Emory Univ, Dept Internal Med, Atlanta, GA 30322 USA
[2] Amer Univ Beirut, Dept Internal Med, Med Ctr, Beirut 11072020, Lebanon
[3] Amer Univ Beirut, Dept Surg, Div Urol, Med Ctr, Beirut 11072020, Lebanon
[4] Amer Univ Beirut, Dept Internal Med, Div Hematol Oncol, Med Ctr, Beirut 11072020, Lebanon
来源
ECANCERMEDICALSCIENCE | 2022年 / 16卷
基金
美国国家卫生研究院;
关键词
muscle invasive bladder cancer; radical cystectomy; trimodal therapy; risk calculator; LONG-TERM OUTCOMES; 90-DAY MORTALITY; SURVIVAL; THERAPY;
D O I
10.3332/ecancer.2022.1456
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Radical cystectomy (RC) for muscle invasive bladder cancer (MIBC) remains the historical gold standard for treatment despite significant perioperative morbidity and subsequent quality of life concerns. Trimodal therapy (TMT) is gaining acceptance as an alternative bladder preserving approach. We aim to identify patients for whom TMT may be the optimal approach by constructing risk calculators of morbidity and mortality asso-ciated with RC. Methods: Using the American College of Surgeons National Surgical Quality Improve-ment Program database, we selected patients diagnosed with MIBC undergoing RC, with a total of 10,642 patients identified. The primary outcome was mortality and second-ary outcome was morbidity within 30 days of the procedure. We conducted multivariate logistic regression to obtain the best fit model for each outcome on 70% of the sample. Validation of the models was then performed on the remaining 30% of the sample. Model performance was assessed using discrimination and calibration abilities and a risk calcula-tor was constructed for pre-operative counselling. Results: Of the full cohort, 199 patients (1.9%) died and 2,328 patients (21.9%) expe-rienced morbidity. Variables selected for the model predicting mortality included age, frailty, the American Society of Anesthesiologists status and preoperative creatinine. For the mortality model, the area under the curve was 72% with a Hosmer-Lemeshow sta-tistic of 0.722. For the morbidity model, the area under the curve was 60% with a Hos-mer-Lemeshow statistic of 0.287. Variables significant in the model included continent diversion, smoking and frailty. Conclusion: We have constructed statistically significant and clinically relevant models using readily available health indicators to be used in multi-disciplinary discussion to provide high-risk patients with individualised risks of morbidity and mortality from RC, allowing for counselling for alternative treatments such as TMT.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Muscle-Invasive Bladder Cancer and Radical Cystectomy
    Hakenberg, Oliver W.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (01) : 1 - 1
  • [2] Delays in radical cystectomy for muscle-invasive bladder cancer
    Chu, Alice T.
    Holt, Sarah K.
    Wright, Jonathan L.
    Ramos, Jorge D.
    Grivas, Petros
    Yu, Evan Y.
    Gore, John L.
    CANCER, 2019, 125 (12) : 2011 - 2017
  • [3] RADICAL CYSTECTOMY FOR INVASIVE BLADDER CANCER
    STONE, JH
    HODGES, CV
    JOURNAL OF UROLOGY, 1966, 96 (02): : 207 - &
  • [4] Age and risk of major complications in patients undergoing radical cystectomy for muscle invasive bladder cancer
    Adamczyk, Przemyslaw
    Kadlubowski, Mateusz
    Poblocki, Pawel
    Adamowicz, Jan
    Ostrowski, Adam
    Drewa, Tomasz
    Juszczak, Kajetan
    VIDEOSURGERY AND OTHER MINIINVASIVE TECHNIQUES, 2021, 16 (04) : 722 - 727
  • [5] Non-muscle-invasive bladder cancer: The role of radical cystectomy
    Chang, SS
    Cookson, MS
    UROLOGY, 2005, 66 (05) : 917 - 922
  • [6] Radical Cystectomy and the Multidisciplinary Management of Muscle-Invasive Bladder Cancer
    Chedgy, Edmund Charles Paul
    Black, Peter C.
    JAMA ONCOLOGY, 2016, 2 (07) : 855 - 856
  • [7] SEX DIFFERENCES IN MUSCLE-INVASIVE BLADDER CANCER WITH RADICAL CYSTECTOMY
    Liblik, Kiera
    Whitehead, Marlo
    Siemens, Robert
    JOURNAL OF UROLOGY, 2024, 211 (05): : E342 - E343
  • [8] Radical cystectomy in the treatment of non-muscle-invasive bladder cancer
    Safiullin, K. N.
    Karyakin, O. B.
    ONKOUROLOGIYA, 2012, 8 (02): : 40 - 43
  • [9] TRIMODAL THERAPY VERSUS RADICAL CYSTECTOMY FOR MUSCLE INVASIVE BLADDER CANCER - A MARKOV MICROSIMULATION MODEL
    Magee, Diana
    Cheung, Douglas
    Hird, Amanda
    Sridhar, Srikala
    Catton, Charles
    Chung, Peter
    Berlin, Alejandro
    Warde, Padraig
    Zlotta, Alexandre
    Fleshner, Neil
    Kulkarni, Girish
    JOURNAL OF UROLOGY, 2020, 203 : E1012 - E1012
  • [10] TRIMODAL THERAPY VERSUS RADICAL CYSTECTOMY FOR MUSCLE INVASIVE BLADDER CANCER - A MARKOV MICROSIMULATION MODEL
    Magee, Diana
    Cheung, Douglas
    Hird, Amanda
    Sridhar, Srikala
    Warde, Padraig
    Catton, Charles
    Berlin, Alejandro
    Chung, Peter
    Zlotta, Alexandre
    Fleshner, Neil
    Kulkarni, Girish
    MEDICAL DECISION MAKING, 2020, 40 (01) : E312 - E313